Scholars@Duke

Dual antiangiogenesis reduces PSA by 50% in most patients: Commentary

Publication ,  Journal Article
George, DJ
Published in: Oncology Report
September 1, 2008

Duke Scholars

Daniel James George
Author Daniel James George Medicine, Medical Oncology

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

September 1, 2008

Issue

FALL

Start / End Page

41

Related Subject Headings

  • Oncology & Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
George, D. J. (2008). Dual antiangiogenesis reduces PSA by 50% in most patients: Commentary. Oncology Report, (FALL), 41.
George, D. J. “Dual antiangiogenesis reduces PSA by 50% in most patients: Commentary.” Oncology Report, no. FALL (September 1, 2008): 41.
George DJ. Dual antiangiogenesis reduces PSA by 50% in most patients: Commentary. Oncology Report. 2008 Sep 1;(FALL):41.
George, D. J. “Dual antiangiogenesis reduces PSA by 50% in most patients: Commentary.” Oncology Report, no. FALL, Sept. 2008, p. 41.
George DJ. Dual antiangiogenesis reduces PSA by 50% in most patients: Commentary. Oncology Report. 2008 Sep 1;(FALL):41.

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

September 1, 2008

Issue

FALL

Start / End Page

41

Related Subject Headings

  • Oncology & Carcinogenesis